Cepheid stock has been delisted and is no longer actively trading. Cepheid is now a division of Danaher Corporation (NYSE:DHR). Cepheid (CPHD) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock CPHD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Oxford Nanopore and Cepheid Collaborate on Sequencing SolutionsApril 9, 2025 | tipranks.comIn The Fight To End Tuberculosis, This Is The Moment For ProgressNovember 15, 2023 | forbes.comReducing the spread of hepatitis CJuly 22, 2023 | bbc.comBSpotSee Forms Life Science Advisory Council with Global Industry LeadersJune 27, 2023 | it.tmcnet.comCepheid (CPHD) Showing Signs Of Being Water-Logged And Getting WetterMay 14, 2023 | thestreet.comGlobal Biochips Market Research Report 2022: Market to Surpass $25+ Billion by 2026 - ResearchAndMarkets.com - Business WireOctober 13, 2022 | businesswire.comThe Worldwide Infectious Disease In Vitro Diagnostics Industry is Expected to Reach $56.6 Billion by 2030 - ResearchAndMarkets.com - Business WireOctober 7, 2022 | businesswire.comGlobal Infectious Disease In Vitro Diagnostics Market Report (2022 to 2030) - High Demand for PoC Facilit - BenzingaOctober 7, 2022 | benzinga.comGlobal COVID-19 Testing Industry - GlobeNewswireOctober 6, 2022 | globenewswire.comLucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays - GlobeNewswireSeptember 30, 2022 | globenewswire.comKey Reasons to Retain Danaher (DHR) Stock in Your Portfolio - NasdaqSeptember 30, 2022 | nasdaq.comLucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays - Yahoo FinanceSeptember 29, 2022 | finance.yahoo.comLucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays - StreetInsider.comSeptember 29, 2022 | streetinsider.comSystemOne Wins Multi-Country, Multi-Device Subcontract through the Infectious Disease Detection and Surveillance Project - StreetInsider.comSeptember 28, 2022 | streetinsider.comGlobal Oncology Molecular Diagnostics Market Report 2022: A $7.28 Billion Market by 2027 - Rise in Demand for Point-of-care Treatment - PR NewswireSeptember 20, 2022 | prnewswire.comWorldwide Tuberculosis Diagnosis and Treatment Industry to 2028 - by Diagnosis, Drugs, End-user and Region - ResearchAndMarkets.com - Business WireSeptember 16, 2022 | businesswire.comDanaher (DHR) to Spin-Off Environmental Unit, Shares Pop - NasdaqSeptember 15, 2022 | nasdaq.comGlobal Oncology Molecular Diagnostics Markets, 2022-2027 - Rising Number of R&D Activities & Technological Advancements in Diagnostic Testing - ResearchAndMarkets.com - Business WireSeptember 14, 2022 | businesswire.comHow monkeypox could help Karius underscore case for its broad pathogen test - San Francisco Business Times - The Business JournalsSeptember 2, 2022 | bizjournals.comWith 6.1% CAGR, Global Tuberculosis Diagnostics Market Size Worth USD 3.13 Billion during Forecast [2022-2029] - GlobeNewswireAugust 29, 2022 | globenewswire.comWith 4.1% CAGR, Canada Sexually Transmitted Disease Testing Market Size worth USD 310.5 Million in 2028 - Report by Fortune Business Insights - GlobeNewswireAugust 24, 2022 | globenewswire.com Get Cepheid News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CPHD Media Mentions By Week CPHD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPHD News Sentiment▼0.001.16▲Average News Sentiment CPHD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPHD Articles This Week▼00▲CPHD Articles Average Week Get the Latest News and Ratings for CPHD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cepheid and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Amgen News Gilead Sciences News Vertex Pharmaceuticals News Regeneron Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News Neurocrine Biosciences News Exelixis News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CPHD) was last updated on 9/29/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cepheid Please log in to your account or sign up in order to add this asset to your watchlist. Share Cepheid With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CPHD Stock Alerts